| abstract |
The present invention relates to methods for treating human cancer and pharmaceutical combinations useful for such treatment. In particular, this method comprises 2-[(5-chloro-2-{[3-methyl-1- (1-methylethyl) -1H-pyrazol-5-yl] amino} -4-pyridinyl) amino] -N. -(Methyloxy) benzamide or a pharmaceutically acceptable salt thereof and N- {3- [3-cyclopropyl-5- (2-fluoro-4-iodo-phenylamino) 6,8-dimethyl-2, 4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido [4,3-d] pyrimidin-1-yl] phenyl} acetamide or a pharmaceutically acceptable salt or solvate thereof. And a method for treating cancer comprising administering to a human in need of cancer treatment. |